# Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study

> **NCT00001217** · PHASE3 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 260 (—)

## Conditions studied

- Osteosarcoma

## Interventions

- **DRUG:** pre-surgical chemotherapy

## Key facts

- **NCT ID:** NCT00001217
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1987-05
- **Primary completion:** —
- **Final completion:** 2000-12
- **Target enrollment:** 260 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001217, "Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00001217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*